Covid-19. Relationship between AstraZeneca vaccine and blood clots is “plausible but not confirmed”, says WHO – Observer

Covid-19. Relationship between AstraZeneca vaccine and blood clots is “plausible but not confirmed”, says WHO – Observer
Covid-19. Relationship between AstraZeneca vaccine and blood clots is “plausible but not confirmed”, says WHO – Observer

A link between AstraZeneca’s Covid-19 vaccine and the development of a rare form of blood clots is “plausible but unconfirmed,” the World Health Organization (WHO) said on Wednesday.

Based on current information, a causal relationship between the vaccine and the occurrence of low-platelet blood clots is considered plausible, but has not been confirmed. Specialized studies are needed to fully understand the potential relationship between vaccination and possible risk factors, ”says the WHO in a statement from the Advisory Committee on vaccine safety.

The organism, says in the statement, analyzed rare cases of blood clots with low platelets after the AstraZeneca vaccine, and also analyzed the latest information from the European Medicines Agency (EMA) and the Medicines and Other Health Products Agency UK.

WHO experts add that they will continue to collect more data but note that, while worrying, the cases under assessment they are “very rare” among the nearly 200 million people who have received the AstraZeneca vaccine worldwide. WHO stresses that there is a need to assess the risk of these “adverse events” in relation to the risk of death from contracting Covid-19 disease, a disease that in the world has already killed at least 2.6 million people.

PUB • CONTINUE READING NEXT

Affirming that side effects are common in the three days after the vaccine, the WHO mentions several symptoms that should take people to see a doctor.

“WHO is carefully monitoring the launch of all Covid-19 vaccines and will continue to work closely with countries to manage potential risks, and to use science and data to drive response and recommendations,” he says. the organization in the statement.

The Joint Committee on Vaccination and Immunization, a support body for the British government, defended this Wednesday that authorities should offer an alternative vaccine to AstraZeneca against Covid-19 to people under 30, due to the growing signs that can cause thromboembolism.

The EMA also disclosed that there is a “possible relationship” between the vaccine against Covid-19 by the pharmaceutical company AstraZeneca and the formation of “very rare cases” of blood clots, but insisted on the benefits of the drug due to the serious consequences of the pandemic.

The Portuguese Presidency of the European Union will hold an emergency meeting on the community vaccination strategy this Wednesday after the disclosure of the conclusions on the AstraZeneca drug.

Get the latest news delivered to your inbox

Follow us on social media networks

PREV Porto Alegre expands Covid-19 vaccination for 64-year olds this Thursday
NEXT Covid-19. Italian businessmen take to the streets in protest for restrictions